企冷帽对化疗诱导的脱发症的回顾性评估
Dale Weaver1, Michelle L Pershing2, Bethany Golden3
1OhioHealth Cancer Care, 3535 Olentangy River Road Columbus, Columbus, OH, 43214, USA. Dale.Weaver@ohiohealth.com.
概括
手动冷盖有效地减少化疗引起的脱发症 (CIA),92.1%的患者保留了显著的头发. 种族或头发类型对疗效没有影响,但化疗疗法发挥了作用.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 患者护理 患者护理
背景情况:
- 头皮冷却是一种非药理方法,用于减少化疗诱导的脱发 (CIA).
- 现有的头皮冷却系统的有效性各不相同,实际数据有限.
- 手动冷盖系统提供了一个潜在的解决方案,以尽量减少CIA.
研究的目的:
- 评估手动冷盖系统的现实世界耐受性和主观有效性.
- 评估患者种族和头发类型对冷盖结果的影响.
- 确定影响手动冷盖成功的因素,以尽量减少CIA.
主要方法:
- 对接受化疗的100名成年患者进行了回顾性队列研究.
- 数据收集包括人口统计,化疗方案,头发特征和主观头发保留.
- 成功的 (≥50%的头发保留) 与不成功的冷盖结果的比较.
主要成果:
- 95%的患者完成了手动冷封闭协议.
- 头发保留的中位数为75%,其中92.1%的患者达到≥50%的头发保留.
- 化疗疗方案与成功率相关;基于多克索鲁比辛的疗法与帕克利塔克塞尔 (95.7%) 和多塞塔克塞尔 (96.6%) 相比,其保留率较低 (71.4%).
- 根据患者的种族或头发特征,没有观察到成功的显著差异.
结论:
- 手动冷盖显示出高效率 (92.1%) 在最小化CIA在这个队列.
- 严格遵守冷盖协议可能有助于成功的结果.
- 对优化不同化疗方案的冷封闭协议的进一步研究是有必要的.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200


